» Articles » PMID: 25062746

The Free and Cued Selective Reminding Test Distinguishes Frontotemporal Dementia from Alzheimer's Disease

Overview
Specialties Neurology
Psychology
Date 2014 Jul 27
PMID 25062746
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Memory impairment is often present in frontotemporal dementia (FTD) as a result of an inefficient use of learning strategies, sometimes leading to a misdiagnosis of Alzheimer's disease (AD). The Free and Cued Selective Reminding Test (FCSRT) is a memory test that controls attention and acquisition, by providing category cues in the learning process. The main goal of this study was to show the usefulness of the FCSRT in the distinction between behavioral (bv-) FTD and AD. Three matched subgroups of participants were considered: bv-FTD (n = 32), AD (n = 32), and a control group of healthy adults (n = 32). Results proved that while AD patients exhibited an overall impairment in FCSRT, bv-FTD subjects showed to benefit more from the controlled learning through category cues. AD patients were 25 times more likely to have an impaired FCSRT. The FCSRT has shown its utility in the distinction between bv-FTD and AD, therefore increasing the diagnostic accuracy.

Citing Articles

Impact of Lewy bodies disease on visual skills and memory abilities: from prodromal stages to dementia.

Busse C, Mitolo M, Mozzetta S, Venneri A, Cagnin A Front Psychiatry. 2024; 15:1461620.

PMID: 39720441 PMC: 11666550. DOI: 10.3389/fpsyt.2024.1461620.


Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS.

Chatterjee M, Ozdemir S, Fritz C, Mobius W, Kleineidam L, Mandelkow E Nat Med. 2024; 30(6):1771-1783.

PMID: 38890531 PMC: 11186765. DOI: 10.1038/s41591-024-02937-4.


A systematic review of cognitive and behavioral tools to differentiate behavioral variant frontotemporal dementia from other conditions.

Flavell J, Nestor P PCN Rep. 2024; 3(2):e210.

PMID: 38887313 PMC: 11180949. DOI: 10.1002/pcn5.210.


NeuroAIreh@b: an artificial intelligence-based methodology for personalized and adaptive neurorehabilitation.

Faria A, Almeida Y, Branco D, Camara J, Cameirao M, Ferreira L Front Neurol. 2024; 14:1258323.

PMID: 38322797 PMC: 10846403. DOI: 10.3389/fneur.2023.1258323.


Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder.

Fernandez-Pereira C, Penedo M, Rivera-Baltanas T, Perez-Marquez T, Alves-Villar M, Fernandez-Martinez R Int J Mol Sci. 2023; 24(20).

PMID: 37894932 PMC: 10607273. DOI: 10.3390/ijms242015254.


References
1.
Freitas S, Simoes M, Alves L, Santana I . Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord. 2011; 27(1):37-43. DOI: 10.1097/WAD.0b013e3182420bfe. View

2.
Blumenfeld R, Ranganath C . Prefrontal cortex and long-term memory encoding: an integrative review of findings from neuropsychology and neuroimaging. Neuroscientist. 2007; 13(3):280-91. DOI: 10.1177/1073858407299290. View

3.
Cummings J, Mega M, Gray K, Carusi D, Gornbein J . The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994; 44(12):2308-14. DOI: 10.1212/wnl.44.12.2308. View

4.
Squire L . Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev. 1992; 99(2):195-231. DOI: 10.1037/0033-295x.99.2.195. View

5.
Geerlings M, Jonker C, Bouter L, Ader H, Schmand B . Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition. Am J Psychiatry. 1999; 156(4):531-7. DOI: 10.1176/ajp.156.4.531. View